Short report: Epidemiological study of the association between anti-Lutzomyia longipalpis saliva antibodies and development of delayed-type hypersensitivity to Leishmania antigen

American Journal of Tropical Medicine and Hygiene

Volumn 83, Issue 4, 2010, Pages 825-827

  Aquino, Dorlene M C ^a   Caldas, Arlene J M ^a   Miranda, José Carlos ^b   Silva, Antonio A M ^a   Barral Netto, Manoel ^b,c,d   Barral, Aldina ^b,c,d  

^a FEDERAL UNIVERSITY OF MARANHÃO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^d Instituto Nacional de Ciencia e Tecnologia de Investigacao em Imunologia iii INCT   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; PARASITE ANTIGEN; ANTIBODY;

ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CHILD; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DELAYED HYPERSENSITIVITY; ENDEMIC DISEASE; FOLLOW UP; HUMAN; IMMUNE RESPONSE; KAPLAN MEIER METHOD; LUTZOMYIA; LUTZOMYIA LONGIPALPIS; MAJOR CLINICAL STUDY; NONHUMAN; PROSPECTIVE STUDY; SALIVA ANALYSIS; VISCERAL LEISHMANIASIS; ANIMAL; BLOOD; IMMUNOLOGY; INFANT; LEISHMANIA; NEWBORN; PRESCHOOL CHILD; PSYCHODIDAE;

ANIMALIA; LUTZOMYIA LONGIPALPIS;

ANIMALS; ANTIBODIES; ANTIGENS, PROTOZOAN; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; HUMANS; HYPERSENSITIVITY, DELAYED; INFANT; INFANT, NEWBORN; LEISHMANIA; LEISHMANIASIS, VISCERAL; PSYCHODIDAE;

EID: 79958056974     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2010.10-0182     Document Type: Article

References (19)

1. World Health Organization, 2002. Urbanization: an increasing risk factor for leishmaniasis. Wkly Epidemiol Rec 77: 6.
2. Brazil Ministério da Saúde, 2006. Leishmaniose visceral (calazar). Distribuição de casos confirmados, por Unidade Federada. Brasil, 1980-2005. Available at: http://portal.saúde.gov.br/portal/ arquivos/pdf/leish-visceral.pdf.
3. World Health Organization, 2010. Research to support the elimination of visceral leishmaniasis. Available at: http://apps.who.int/tdr/svc/research/ visceral-leishmaniasis-elimination.
4. Theodos CM, Ribeiro JM, Titus RG, 1991. Analysis of enhancing effect of sand fly saliva on Leishmania infection in mice. Infect Immun 59: 1592-1598.
5. Samuelson J, Lerner E, Tesh R, Titus R, 1991. A mouse model of Leishmania braziliensis braziliensis infection produced by coinjection with sand fly saliva. J Exp Med 173: 49-54.
6. Warburg A, Saraiva E, Lanzaro GC, Titus RG, Neva F, 1994. Saliva of Lutzomyia longipalpis sibling species differs in its composition and capacity to enhance leishmaniasis. Philos Trans R Soc Lond B Biol Sci 345: 223-230. (Pubitemid 2118718)
7. Lima HC, Titus RG, 1996. Effects of sand fly vector saliva on development of cutaneous lesions and the immune response to Leishmania braziliensis in BALB/c mice. Infect Immun 64: 5442-5445. (Pubitemid 26404021)
8. Belkaid Y, Kamhawi S, Modi G, Valenzuela J, Noben-Trauth N, Rowton E, Ribeiro J, Sacks DL, 1998. Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis. J Exp Med 188: 1941-1953. (Pubitemid 28536781)
9. Norsworthy NB, Sun J, Elnaiem D, Lanzaro G, Soong L, 2004. Sand fly saliva enhances Leishmania amazonensis infection by modulating interleukin-10 production. Infect Immun 72: 1240-1247. (Pubitemid 38263741)
10. Valenzuela JG, Belkaid Y, Garfield MK, Mendez S, Kamhawi S, Rowton ED, Sacks DL, Ribeiro JM, 2001. Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein. J Exp Med 194: 331-342. (Pubitemid 32730807)
11. Morris RV, Shoemaker CB, David JR, Lanzaro GC, Titus RG, 2001. Sandfly maxadilan exacerbates infection with Leishmania major and vaccinating against it protects against L. major infection. J Immunol 167: 5226-5230. (Pubitemid 33009759)
12. Kamhawi S, Belkaid Y, Modi G, Rowton E, Sacks D, 2000. Protection against cutaneous leishmaniasis resulting from bites of uninfected sand flies. Science 290: 1351-1354.
13. Vinhas V, Andrade BB, Paes F, Bomura A, Clarencio J, Miranda JC, Báfica A, Barral A, Barral-Netto M, 2007. Human anti-saliva immune response following experimental exposure to the visceral leishmaniasis vector, Lutzomyia longipalpis. Eur J Immunol 37: 3111-3121. (Pubitemid 350131290)
14. Gomes RB, Brodskyn C, de Oliveira CI, Costa J, Miranda JC, Caldas A, Valenzuela JG, Barral-Netto M, Barral A, 2002. Seroconversion against Lutzomyia longipalpis saliva concurrent with the development of anti-Leishmania chagasi delayed-type hypersensitivity. J Infect Dis 186: 1530-1534. (Pubitemid 35286128)
15. Oliveira F, Lawyer PG, Kamhawi S, Valenzuela JG, 2002. Immunity to distinct sand fly salivary proteins primes the anti-Leishmania immune response towards protection or exacerbation of disease. PLoS Negl Trop Dis 2: e226.
16. Reed SG, Badaro R, Masur H, Carvalho EM, Lorenco R, Lisboa A, Teixeira R, Johnson WD Jr, Jones TC, 1986. Selection of a skin test antigen for American visceral leishmaniasis. Am J Trop Med Hyg 35: 79-85. (Pubitemid 16140841)
17. Barral A, Honda E, Caldas A, Costa J, Vinhas V, Rowton ED, Valenzuela JG, Charlab R, Barral-Netto M, Ribeiro M, 2000. Human immune response to sand fly salivary gland antigens: a useful epidemiological marker? Am J Trop Med Hyg 62: 740-745. (Pubitemid 32281497)
18. Belkaid Y, Valenzuela JG, Kamhawi S, Rowton E, Sacks DL, Ribeiro JM, 2000. Delayed-type hypersensitivity to Phlebotomus papatasi sand fly bite: an adaptive response induced by the fly? Proc Natl Acad Sci USA 97: 6704-6709. (Pubitemid 30412778)
19. Souza AP, Andrade BB, Aquino D, Entringer P, Miranda JC, Alcantara R, Ruiz D, Soto M, Teixeira CR, Valenzuela JG, de Oliveira CI, Brodskyn CI, Barral-Netto M, Barral A, 2010. Using recombinant proteins from Lutzomyia longipalpis saliva to estimate human vector exposure in visceral leishmaniasis endemic areas. PLoS Negl Trop Dis 4: e649.